Is this calculator for Mounjaro or Zepbound pens?
No. FDA-supplied ready-to-use products have their own labels and are not user-reconstituted. This page calculates only from values manually entered by a visitor.
Tirzepatide Reconstitution Calculator
Classification: Synthetic peptide dual GIP and GLP-1 receptor agonist
Overview
Tirzepatide is a synthetic peptide designed to activate both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual-receptor classification is stated in FDA labeling and distinguishes tirzepatide from medicines that act at only one of those receptors. Mounjaro and Zepbound are product names, not interchangeable labels for every tirzepatide-containing material.
The approved-product distinction is central to this page. FDA labeling describes manufacturer-supplied products with their own concentrations, presentations, and instructions. Those products are ready-to-use in the sense relevant to this calculator brief: the consumer does not use this page to recreate the manufacturer’s product. PepLedger instead provides a neutral arithmetic interface for a visitor who has a separate, verified label value to enter.
The visitor supplies the vial or container mass, the liquid volume associated with that entry, an amount to calculate, and a display scale. The interface does not prefill a target, identify a product, or transform an approved label into a preparation plan. A calculated value is conditional on the submitted data and says nothing about whether the data describe Mounjaro, Zepbound, an investigational material, or an incorrectly labelled container.
Concentration is a relationship between entered mass and entered liquid volume. If either entry changes, the arithmetic relationship changes. A syringe scale is a volume display, not a tirzepatide unit. U-100 or U-40 markings become interpretable only after a concentration has been calculated using the visitor’s own values. This is why an identical scale position may represent different mass values in different labelled contexts.
Tirzepatide labeling can change over time as regulators review additional evidence. The sources listed here are intended to anchor the status statement to official records available on the reviewed date. They are not a replacement for checking the current label for a specific approved product. PepLedger does not copy prescribing or administration directions from those labels.
This page cannot check identity, purity, sterility, concentration, compatibility, or whether an entered value belongs to the named product. Product-specific questions belong with the applicable official label and a qualified professional.
Research context
Tirzepatide entered clinical development through studies of its dual incretin pharmacology and has accumulated a substantial clinical literature. Study findings remain tied to their population, design, comparator, endpoints, and product context. A result from a trial is not a calculator preset and is not a direction for an individual.
Evidence and regulatory status
FDA Mounjaro and Zepbound labels support the receptor classification and approved product context. The EMA Mounjaro record provides a separate regulator’s product information. The PubMed review records the development history. These sources do not make a visitor-entered value an approved product value.
Unit notes
Mass entries may be mg or mcg. The universal relationship is 1 mg = 1,000 mcg.
U-100 means 100 units per mL and U-40 means 40 units per mL. They describe display scales and are not tirzepatide-specific directions.
Mass cannot be read from a syringe scale without a concentration derived from the visitor’s entered values.
Limitations
- A mathematical output cannot validate a label or decide whether a person should use a medicine. It cannot identify a product presentation, infer an unprinted concentration, or confirm that a visitor’s mass and volume belong together.
Frequently asked questions
What does the tirzepatide calculator return?
It returns an arithmetic concentration, a calculated volume in mL, and a syringe-scale position after required visitor-entered values are present.
Does PepLedger choose a tirzepatide amount?
No. PepLedger does not determine or recommend an amount. It performs arithmetic using values entered by the visitor.
Why are Mounjaro and Zepbound listed as aliases?
They are FDA product names associated with tirzepatide, but aliases do not make their labels, presentations, or approved contexts interchangeable.
What does dual GIP and GLP-1 mean?
It describes the two receptor systems that FDA labeling identifies for tirzepatide. It is a pharmacology classification, not a personal outcome statement.
Can a syringe unit be converted directly to tirzepatide mass?
No. A syringe unit is a volume-scale marking. Concentration and consistent units are required before mass can be represented.
Sources and official references
- MOUNJARO (tirzepatide) Injection Prescribing Information — U.S. Food and Drug Administration (2022)
- ZEPBOUND (tirzepatide) Injection Prescribing Information — U.S. Food and Drug Administration (2024)
- Mounjaro, INN-tirzepatide: EPAR Assessment Report — European Medicines Agency (2025)
- Tirzepatide: First Approval — PubMed / Drugs (2022)
Calculation methodology
PepLedger calculates concentration, liquid volume and syringe-scale position exclusively from the values you enter. It does not choose or recommend an amount.
View our calculation methodology and editorial standards
Last updated: September 13, 2026